Episode 47 - Marc Lajoie, CEO at Outpace Bio
"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells. Tune in today!
Episode 47 of the Few & Far Between: How Biotech Gets Built podcast, hosted by Chris O'Brien, titled "Episode 47 - Marc Lajoie, CEO at Outpace Bio" was published on December 31, 2024 and runs 48 minutes.
December 31, 2024 ·48m · Few & Far Between: How Biotech Gets Built
Summary
"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells. Tune in today!
Episode Description
"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio
Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells.
Tune in today!
Similar Episodes
Apr 13, 2026 ·17m
Apr 6, 2026 ·11m
Mar 30, 2026 ·17m
Mar 23, 2026
Mar 16, 2026